Condition: ARDS · Sponsor: Sanjay Gandhi Postgraduate Institute of Medical Sciences
Acute respiratory distress syndrome (ARDS) is a life-threatening condition requiring respiratory support to maintain oxygenation. Very few biomarkers about ARDS have been identified but none of them has a sufficient specificity or sensitivity to characterize by itself the severity of lung condition. Investigators hypothesize that there is considerable change occurring in metabolic profiles in mild, moderate, and severe ARDS in comparison to healthy cohort, which can be detectable through serum analysis using NMR based metabolomics study. This research would help to understand metabolomics kinetics during the ARDS disease progression. Overall, NMR-based metabolomics study would provide an insight into the mediators involved in pathogenesis and progression of ARDS.
This description comes directly from the study's public registry record.
Mohan Gurjar, MD, PDCC · +91-522-249-5403 · m.gurjar@rediffmail.com
Neeraj Sinha, M.Sc., Ph.D. · 05222495031 · neerajcbmr@gmail.com
Always discuss trial participation with your own doctor first.
| Centre of Biomedical Research | Lucknow, Uttar Pradesh, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06036056